Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

22.22 -0.46 (-2.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axogen, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Keep an eye on the top gainers and losers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Earnings Scheduled For October 29, 2025
 
Via Benzinga
Why Is Axogen Stock Down 11% In Pre-Market Today?
Via Stocktwits
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Axogen Inc (NASDAQ:AXGN) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance
Axogen (AXGN) stock surged after Q3 2025 earnings beat estimates. Revenue grew 23.5% to $60.1M, while adjusted EPS of $0.12 crushed forecasts. The company also raised its full-year guidance. 
Via Chartmill
Topics Earnings
Axogen, Inc. Reports Third Quarter 2025 Financial Results
Raises Full Year Revenue Guidance to at Least 19% Growth or $222.8 million 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN
From DJS Law Group
Via Business Wire
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
 
Via Benzinga
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full-year revenue outlook. 
Via Benzinga
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted
The FDA's move is largely procedural, says one analyst, but it adds incremental uncertainty. 
Via Investor's Business Daily
Which stocks are moving before the opening bell on Monday?
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
FDA PDUFA goal date extended by three months 
From Axogen, Inc.
Via GlobeNewswire
Axogen (AXGN) Q2 Revenue Jumps 18%
Via The Motley Fool
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance
Axogen Inc (AXGN) surpasses Q2 2025 estimates with strong revenue and EPS growth, raises full-year guidance, sparking a 15.8% pre-market stock surge. 
Via Chartmill
Topics Earnings
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Axogen, Inc. Reports Second Quarter 2025 Financial Results
Raises Full Year Revenue Guidance to at Least 17% Growth or $219 Million 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
From Axogen, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.